Prescrire Int. 2012 Sep;21(130):220-3.
Amalyste is a French patient-advocacy group for victims of two very serious adverse drug reactions: Lyell and Stevens-Johnson syndromes. The aims of this organisation are to represent the interests of patients who have experienced these syndromes; to better inform the public about these syndromes; to provide analyses of drug-related risks; and to demand collective compensation for victims of serious adverse drug reactions. The following text is our translation of an Amalyste position statement on drug-related risks. It provides valuable food for thought, both for healthcare professionals and for drug regulatory agencies, and has the potential to improve practice (a).
“分析小组”是一个法国患者权益倡导组织，致力于为莱尔综合征和史蒂文斯 - 约翰逊综合征这两种非常严重的药物不良反应的受害者发声。该组织的目标是代表经历过这些综合征的患者的利益；让公众更好地了解这些综合征；提供与药物相关风险的分析；并要求为严重药物不良反应的受害者提供集体赔偿。以下文本是我们对“分析小组”关于药物相关风险的立场声明的翻译。它为医疗保健专业人员和药品监管机构提供了有价值的思考内容，并有改善实际做法的潜力（a）。
